Cargando...
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...
Gardado en:
| Publicado en: | Clin Mol Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/ https://ncbi.nlm.nih.gov/pubmed/31080365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|